How to Read a Peptide Certificate of Analysis (CoA) | Veyvora

A peptide certificate of analysis (CoA) is a batch-specific analytical report that documents identity, purity, content and selected quality attributes of a research peptide, compared against pre-defined specifications, to support batch release and traceability [1].

This guide shows how to verify that a CoA belongs to the physical batch in hand, what each analytical field reports, and which attributes are covered by other records.

How to read a peptide CoA, the core steps:

1. Confirm the batch or lot number on the CoA matches the pen label exactly; the certificate reports the lot whose number it carries.
2. Check product identity fields: peptide name, sequence, molecular formula and theoretical molecular weight.
3. Review High-Performance Liquid Chromatography (HPLC) purity as an area-percentage value, and request the chromatogram to verify peak integration.
4. Examine the mass spectrometry result (observed mass versus theoretical mass) to confirm molecular identity.
5. Read the net peptide content figure, which accounts for residual water and counter-ion mass excluded from the HPLC purity calculation.
6. Verify manufacture and retest dates to confirm the batch sits within its tested stability window.
7. Check that the issuing laboratory is named, the analytical methods are identified, and a qualified signatory has authorised the compliance conclusion.
8. Read endotoxin, bioburden and sterility results as separately reported attributes, each present where that test was run.

Each field answers a different analytical question. HPLC purity measures the proportion of chromatographic signal attributed to the target peptide; concentration, sterility and contaminant clearance are reported by their own tests. Veyvora states that each catalogue batch is checked independently by a third-party laboratory (Asterion Analytics) and again by Veyvora’s own internal testing, using HPLC, mass spectrometry and endotoxin testing, before sale [1].

Key Takeaways

• A CoA is batch-specific: match the lot number to the pen label exactly before reading any result.
• HPLC purity, net peptide content, mass spectrometry and microbiological attributes are four distinct parameters, each with its own method.
• A CoA confirms analytical conformity for the parameters tested: identity, purity, content and the contaminants reported.
• A result appears on the certificate where that test was run; where a figure such as endotoxin is needed, ask for the lot’s report.
• Post-dispatch storage conditions are covered separately; consult storage and stability guidance for research peptides.

Reading the fields of a peptide CoA in sequence is the most reliable way to confirm that a batch meets its stated specification, because each field answers a distinct analytical question [1].

Minimum fields to verify on any peptide CoA:

1. Product identity, peptide name, sequence, molecular formula and theoretical molecular weight, confirming what was synthesised.
2. Batch or lot number, a unique identifier that matches every pen label and accompanying batch document exactly.
3. Manufacture and retest dates, the window within which the analytical results are considered valid; consult storage and stability guidance for research peptides if the retest date is approaching.
4. Physical description, appearance (for a pre-filled solution pen, typically a clear, colourless solution) as a basic conformance check on receipt.
5. HPLC purity, reported as an area-percentage value; request the raw chromatogram to verify peak integration and confirm no co-eluting impurities are obscured.
6. Mass spectrometry result, observed mass versus theoretical mass, confirming molecular identity independently of chromatographic retention.
7. Net peptide content, the proportion of the weighed material that is active peptide, after accounting for residual water and counter-ion mass; this figure is read separately from HPLC purity.
8. Microbiological attributes, endotoxin and bioburden results, where tested; each is reported on the certificate when run.
9. Issuing laboratory identity, name, address and, where applicable, accreditation number.
10. Analytical methods and version numbers, identifies which validated procedure generated each result.
11. Authorised signatory and compliance conclusion, a named, qualified individual’s sign-off confirming the batch meets or does not meet specification.

Unfamiliar terms such as assay, retest date or endotoxin are defined in the research peptide glossary without interrupting the CoA review workflow.

A peptide CoA documents analytical conformity for the parameters tested. The following attributes are covered by other records and studies:

• Sterility. A validated sterility test, where performed, reports freedom from viable micro-organisms; endotoxin testing reports lipopolysaccharide contamination, and viral and non-endotoxin pyrogen testing are further dedicated assays.
• Biological activity and in vivo stability. HPLC purity and mass spectrometry confirm chromatographic and structural properties; receptor binding, immunogenicity and pharmacokinetic behaviour are studied in the relevant biological system.
• Impurities outside the reported methods. A CoA reports the parameters listed; an impurity outside the methods’ scope is characterised by an additional method where a protocol needs it.
• Post-dispatch integrity. The CoA reflects batch status at the time of testing; storage and transit conditions are recorded at receipt and in storage, as set out in storage and stability guidance for research peptides.
• Good Manufacturing Practice (GMP) compliance and sourcing. The manufacturing facility, production process and supply-chain provenance are documented in manufacturing records and supplier qualification [1].

Pharmacopoeial and WHO laboratory guidance place analytical documentation alongside supplier qualification and manufacturing records as the components of a full quality picture [1].

A peptide CoA sits within a broader quality framework; understanding the individual tests it reports calls for separate, method-specific references.

• To understand what HPLC purity measures, including how area-percent values relate to the concentration, identity and sterility results, consult the HPLC purity method explainer before interpreting purity figures from any batch document.
• To apply the batch-matching checks described above to a specific vial or shipment, use the step-by-step verify a CoA against your batch tool, which walks through lot-number cross-referencing, date validation and discrepancy reporting.

Eurachem’s analytical quality guides and European Pharmacopoeia general chapters, including 2.2.55 on peptide mapping and 2.6.14 on bacterial endotoxins, define the procedural standards that underpin the results reported on any compliant CoA [1].

To begin batch verification for a Veyvora research peptide, locate the lot number on your vial and retrieve the corresponding CoA from Veyvora’s research-peptide catalogue.